Thymidylate synthase 3D structures: Difference between revisions

Joel L. Sussman (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
Line 53: Line 53:
**[[4xsd]] - VvTS + dUMP<br />
**[[4xsd]] - VvTS + dUMP<br />
**[[5h39]] – hhvORF70 + UMP<br />
**[[5h39]] – hhvORF70 + UMP<br />
**[[7xyj]] – wssvORF70 + UMP<br />


*Thymidylate synthase binary complex without UMP
*Thymidylate synthase binary complex without UMP
Line 82: Line 83:
*Thymidylate synthase ternary complex with UMP
*Thymidylate synthase ternary complex with UMP


**[[1hvy]], [[1i00]], [[5x5q]], [[5x66]], [[5x67]] - hTS  + drug + UMP<br />
**[[1hvy]], [[1i00]], [[5x5q]], [[5x66]], [[5x67]], [[6zxo]] - hTS  + drug + UMP<br />
**[[5hs3]], [[6pf6]], [[6pf5]], [[6pf4]], [[6pf3]], [[6ojv]], [[6oju]] - hTS  + inhibitor + dUMP<br />
**[[5hs3]], [[6pf6]], [[6pf5]], [[6pf4]], [[6pf3]], [[6ojv]], [[6oju]] - hTS  + inhibitor + dUMP<br />
**[[1ju6]], [[1juj]] - hTS  (mutant) + inhibitor + UMP<br />
**[[1ju6]], [[1juj]] - hTS  (mutant) + inhibitor + UMP<br />
**[[5fct]] - mTS  + inhibitor + fluoro-UMP <br />
**[[5fct]] - mTS  + inhibitor + fluoro-UMP <br />
**[[4eb4]] - mTS  + drug + UMP<br />
**[[4eb4]], [[6y08]] - mTS  + drug + UMP<br />
**[[6gko]] - mTS + phenolphthalein + UMP<br />
**[[6gko]] - mTS + phenolphthalein + UMP<br />
**[[1rts]], [[2tsr]] - TS  + drug + UMP – rat<br />
**[[1rts]], [[2tsr]] - TS  + drug + UMP – rat<br />
Line 117: Line 118:
**[[4fox]], [[4fqs]] - MtTS  + inhibitor + fluoro-UMP <br />
**[[4fox]], [[4fqs]] - MtTS  + inhibitor + fluoro-UMP <br />
**[[6qxs]] - EfTS  + fluoro-dUMP + folate derivative<br />
**[[6qxs]] - EfTS  + fluoro-dUMP + folate derivative<br />
**[[7cca]] - wssvTS + UMP + drug<br />
**[[7cca]], [[7xyk]] - wssvTS + UMP + drug<br />
**[[5h3a]] – hhvORF70 + UMP + drug<br />
**[[5h3a]] – hhvORF70 + UMP + drug<br />
**[[7dp4]], [[7dp5]] – BmaTS + UMP + drug <br />
**[[7dp4]], [[7dp5]] – BmaTS + UMP + drug <br />

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Joel L. Sussman